IP Library › Granted Patent US 12,484,800
Granted Patent B2
US 12,484,800 · App. 18/335,953 · Granted Dec 2, 2025

Systems and methods for calibrating dry electrode bioelectrical impedance sensing

Inventors: Clayton G. Lepak (San Francisco, CA); Reza Naima (San Francisco, CA)
Assignee: TERUMO KABUSHIKI KAISHA
A61B5/0531A61B5/24A61B5/681A61B2560/0238
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,484,800
App. No.
18/335,953
Granted
Dec 2, 2025
Kind
B2
Abstract

Described herein are systems and methods for calibrating dry electrode bioelectrical impedance measurements. These method and apparatuses may be used for sensing bioelectrical impedance for ambulatory and or long-term measurements. Calibration of bioelectrical impedance sensing may be performed by using measurements taken during a shorted configuration of the apparatus, in which the same current is applied to both the source and sink stimulation electrodes, to modify measurements taken in a forward and/or reverse configuration in which current is applied to either the source and/or sink.

Claims (46)

1 . A wearable device for ambulatory measurements of a calibrated bioelectrical impedance of a subject's tissue, comprising:

a frame including a surface that at least partly contacts a skin of the subject when the wearable device is worn by the subject;

a plurality of stimulation electrodes arranged along the surface and including a source electrode and a sink electrode;

a plurality of sense electrodes arranged along the surface and including first and second sense electrodes;

a signal generator electrically connected to the stimulation electrodes;

a current sense resistor electrically connected to the stimulation electrodes; and

a controller configured to:

set an operation mode of the wearable device to a normal mode when the wearable device is worn by the subject,

while the wearable device is operating in the normal mode, control the signal generator to apply a first current between the source and sink electrodes, sense voltages at the first and second sense electrodes, and then automatically switch the operation mode from the normal mode to a shorted mode,

while the wearable device is operating in the shorted mode, control the signal generator to apply a second current simultaneously to both the source and sink electrodes, and sense voltages at the first and second sense electrodes,

determine the calibrated bioelectric impedance based at least in part on: a voltage difference between the first and second sense electrodes in both the normal and shorted modes, a ratio of voltages at one of the first and second sense electrodes in the normal and shorted modes, and a third current across the current sense resistor in the normal mode, and

output the calibrated bioelectric impedance.

2 . The wearable device according to claim 1 , wherein the calibrated bioelectric impedance is determined by the following formula:

Z 2 =(β N −β B *(γ N /γ B ))/(α N /Z 6 )

where Z 2 is the calibrated bioelectric impedance, β N is the voltage difference between the first and second sense electrodes in the normal mode, β B is the voltage difference between the first and second sense electrodes in the shorted mode, γ N /γ B is the ratio of voltages at said one of the first and second sense electrodes in the normal mode and the shorted mode, and α N /Z 6 is the third current across the current sense resistor in the normal mode.

3 . The wearable device according to claim 1 , wherein the controller is configured to:

set the operation mode to a reverse mode, and

while the wearable device is operating in the reverse mode, control the signal generator to apply a fourth current between the sink and source electrodes in a direction opposite to the first current, and sense voltages at the first and second sense electrodes.

4 . The wearable device according to claim 3 , wherein

the controller is configured to determine a first bioelectric impedance based at least in part on the voltages at the first and second sense electrodes in both the normal and shorted modes, and determine a second bioelectric impedance based at least in part on the voltages at the first and second sense electrodes in both the reverse and shorted modes, and

the calibrated bioelectric impedance is determined using the first and second bioelectric impedances.

5 . The wearable device according to claim 4 , wherein the calibrated bioelectric impedance is an average of the first and second bioelectric impedances.

6 . The wearable device according to claim 1 , wherein each of the stimulation and sense electrodes is a dry electrode.

7 . A measurement apparatus for measuring a calibrated bioelectrical impedance of a subject's tissue, comprising:

a frame including a surface that at least partly contacts a skin of the subject;

a plurality of stimulation electrodes arranged along the surface and including a source electrode and a sink electrode;

a plurality of sense electrodes arranged along the surface and including first and second sense electrodes;

a signal generator electrically connected to the stimulation electrodes;

a current sense resistor electrically connected to the stimulation electrodes; and

a controller configured to:

set an operation mode of the measurement apparatus to a normal mode when the surface contacts the skin,

while the measurement apparatus is operating in the normal mode, control the signal generator to apply a first current between the source and sink electrodes, sense voltages at the first and second sense electrodes, and then automatically switch the operation mode from the normal mode to a shorted mode,

while the measurement apparatus is operating in the shorted mode, control the signal generator to apply a second current simultaneously to both the source and sink electrodes, and sense voltages at the first and second sense electrodes,

determine the calibrated bioelectric impedance based at least in part on: a voltage difference between the first and second sense electrodes in both the normal and shorted modes, a ratio of voltages at one of the first and second sense electrodes in the normal and shorted modes, and a third current across the current sense resistor in the normal mode, and

output the calibrated bioelectric impedance.

8 . The measurement apparatus according to claim 7 , wherein the calibrated bioelectric impedance is determined by the following formula:

Z 2 =(β N −β B *(γ N /γ B ))/(α N /Z 6 )

where Z 2 is the calibrated bioelectric impedance, β N is the voltage difference between the first and second sense electrodes in the normal mode, β B is the voltage difference between the first and second sense electrodes in the shorted mode, γ N /γ B is the ratio of voltages at said one of the first and second sense electrodes in the normal mode and the shorted mode, and α N /Z 6 is the third current across the current sense resistor in the normal mode.

9 . The measurement apparatus according to claim 7 , wherein the controller is configured to:

set the operation mode to a reverse mode, and

while the measurement apparatus is operating in the reverse mode, control the signal generator to apply a fourth current between the sink and source electrodes in a direction opposite to the first current, and sense voltages at the first and second sense electrodes.

10 . The measurement apparatus according to claim 9 , wherein

the controller is configured to determine a first bioelectric impedance based at least in part on the voltages at the first and second sense electrodes in both the normal and shorted modes, and determine a second bioelectric impedance based at least in part on the voltages at the first and second sense electrodes in both the reverse and shorted modes, and

the calibrated bioelectric impedance is determined using the first and second bioelectric impedances.

11 . The measurement apparatus according to claim 10 , wherein the calibrated bioelectric impedance is an average of the first and second bioelectric impedances.

12 . The measurement apparatus according to claim 7 , wherein each of the stimulation and sense electrodes is a dry electrode.

Continuity (3)
Division 16714594 · Dec 13, 2019
Provisional Application 62779657 · Dec 14, 2018
Related Publication 20230337929A1 · Oct 26, 2023
References Cited (188)
US 5971930A · Elghazzawi · 1999 [cited by applicant]
US 6496725B2 · Kamada et al. · 2002 [cited by applicant]
US 6516222B2 · Fukuda · 2003 [cited by applicant]
US 6714813B2 · Ishigooka et al. · 2004 [cited by applicant]
US 6821249B2 · Casscells, III et al. · 2004 [cited by applicant]
US 6829496B2 · Nagai et al. · 2004 [cited by applicant]
US 6850788B2 · Al-Ali · 2005 [cited by applicant]
US 6896661B2 · Dekker · 2005 [cited by applicant]
US 7018339B2 · Birnbaum et al. · 2006 [cited by applicant]
US 7024233B2 · Ali et al. · 2006 [cited by applicant]
US 7215987B1 · Sterling et al. · 2007 [cited by applicant]
US 7547279B2 · Kim et al. · 2009 [cited by applicant]
US 7657295B2 · Coakley et al. · 2010 [cited by applicant]
US 7740591B1 · Starr et al. · 2010 [cited by applicant]
US 7761261B2 · Shmueli et al. · 2010 [cited by applicant]
US 7794406B2 · Reisfeld et al. · 2010 [cited by applicant]
US 7976472B2 · Kiani · 2011 [cited by applicant]
US 8092393B1 · Rulkov et al. · 2012 [cited by applicant]
US 8148686B2 · Ryhanen et al. · 2012 [cited by applicant]
US 8175671B2 · Hoarau · 2012 [cited by applicant]
US 8233974B2 · Ward et al. · 2012 [cited by applicant]
US 8328718B2 · Tran · 2012 [cited by applicant]
US 8346328B2 · Mannheimer et al. · 2013 [cited by applicant]
US 8374688B2 · Libbus et al. · 2013 [cited by applicant]
US 8401608B2 · Baker, Jr. et al. · 2013 [cited by applicant]
US 8433383B2 · O'Neil et al. · 2013 [cited by applicant]
US 8437820B2 · Yarita · 2013 [cited by applicant]
US 8600468B2 · Yamamoto et al. · 2013 [cited by applicant]
US 8721555B2 · Westbrook et al. · 2014 [cited by applicant]
US 8744577B2 · Joo et al. · 2014 [cited by applicant]
US 8836345B2 · Chetham et al. · 2014 [cited by applicant]
US 8886271B2 · Kiani et al. · 2014 [cited by applicant]
US 8903484B2 · Mazar · 2014 [cited by applicant]
US 8920332B2 · Hong et al. · 2014 [cited by applicant]
US 8945017B2 · Venkatraman et al. · 2015 [cited by applicant]
US 8954135B2 · Yuen et al. · 2015 [cited by applicant]
US 8956303B2 · Hong et al. · 2015 [cited by applicant]
US 8965471B2 · Lamego · 2015 [cited by applicant]
US 8974396B1 · Brady et al. · 2015 [cited by applicant]
US 8977348B2 · Su et al. · 2015 [cited by applicant]
US 8998815B2 · Venkatraman et al. · 2015 [cited by applicant]
US 9044149B2 · Richards et al. · 2015 [cited by applicant]
US 9044171B2 · Venkatraman et al. · 2015 [cited by applicant]
US 9049998B2 · Brumback et al. · 2015 [cited by applicant]
US 9113794B2 · Hong et al. · 2015 [cited by applicant]
US 9130070B2 · Deliwala et al. · 2015 [cited by applicant]
US 9149235B2 · Ward et al. · 2015 [cited by applicant]
US 9186108B2 · Rodriguez-Llorente et al. · 2015 [cited by applicant]
US 9192310B2 · Rodriguez-Llorente et al. · 2015 [cited by applicant]
US 9241635B2 · Yuen et al. · 2016 [cited by applicant]
US 9241646B2 · Addison et al. · 2016 [cited by applicant]
US 9247884B2 · Yuen et al. · 2016 [cited by applicant]
US 9289167B2 · Diab et al. · 2016 [cited by applicant]
US 9304202B2 · Deliwala · 2016 [cited by applicant]
US 9320443B2 · Libbus et al. · 2016 [cited by applicant]
US 9339236B2 · Frix et al. · 2016 [cited by applicant]
US 9504406B2 · Chetham et al. · 2016 [cited by applicant]
US 9675250B2 · Tverskoy · 2017 [cited by applicant]
US 10004408B2 · Naima · 2018 [cited by applicant]
US 20010020138A1 · Ishigooka et al. · 2001 [cited by applicant]
US 20080214903A1 · Orbach · 2008 [cited by applicant]
US 20080319336A1 · Ward et al. · 2008 [cited by applicant]
US 20100217096A1 · Nanikashvili · 2010 [cited by applicant]
US 20120179006A1 · Jansen et al. · 2012 [cited by applicant]
US 20120253141A1 · Addison et al. · 2012 [cited by applicant]
US 20120283535A1 · Sarussi · 2012 [cited by applicant]
US 20130058358A1 · Fulton et al. · 2013 [cited by applicant]
US 20130072145A1 · Dantu · 2013 [cited by applicant]
US 20130261415A1 · Ashe et al. · 2013 [cited by applicant]
US 20130281800A1 · Saroka et al. · 2013 [cited by applicant]
US 20130303935A1 · Uchiyama et al. · 2013 [cited by applicant]
US 20140018779A1 · Worrell et al. · 2014 [cited by applicant]
US 20140024905A1 · Sarrafzadeh et al. · 2014 [cited by applicant]
US 20140031713A1 · Gaw et al. · 2014 [cited by applicant]
US 20140073952A1 · Rodriguez-Llorente et al. · 2014 [cited by applicant]
US 20140073957A1 · Rodriguez-Llorente et al. · 2014 [cited by applicant]
US 20140073964A1 · Rodriguez-Llorente et al. · 2014 [cited by applicant]
US 20140155759A1 · Kaestle et al. · 2014 [cited by applicant]
US 20140213858A1 · Presura et al. · 2014 [cited by applicant]
US 20140213863A1 · Loseu et al. · 2014 [cited by applicant]
US 20140253709A1 · Bresch et al. · 2014 [cited by applicant]
US 20140276166A1 · Drori et al. · 2014 [cited by applicant]
US 20140288436A1 · Venkatraman et al. · 2014 [cited by applicant]
US 20140309537A1 · Niwa et al. · 2014 [cited by applicant]
US 20140330132A1 · Raskin · 2014 [cited by applicant]
US 20140343371A1 · Sowers et al. · 2014 [cited by applicant]
US 20150038810A1 · Melker · 2015 [cited by applicant]
US 20150065819A1 · Thakur et al. · 2015 [cited by applicant]
US 20150088002A1 · Podhajsky et al. · 2015 [cited by applicant]
US 20150088003A1 · Podhajsky et al. · 2015 [cited by applicant]
US 20150157219A1 · Lee et al. · 2015 [cited by applicant]
US 20150164404A1 · Euliano et al. · 2015 [cited by applicant]
US 20150196256A1 · Venkatraman et al. · 2015 [cited by applicant]
US 20150223760A1 · Greifer · 2015 [cited by applicant]
US 20150257663A1 · Deliwala · 2015 [cited by applicant]
US 20150272488A1 · Ueda et al. · 2015 [cited by applicant]
US 20150335293A1 · Christman et al. · 2015 [cited by applicant]
US 20150366469A1 · Harris et al. · 2015 [cited by applicant]
US 20160015275A1 · Samadani et al. · 2016 [cited by applicant]
US 20160022157A1 · Melker et al. · 2016 [cited by applicant]
US 20160022201A1 · Arnold et al. · 2016 [cited by applicant]
US 20160022220A1 · Lee et al. · 2016 [cited by applicant]
US 20160029898A1 · LeBoeuf et al. · 2016 [cited by applicant]
US 20160058300A1 · Yoon et al. · 2016 [cited by applicant]
US 20160058375A1 · Rothkopf · 2016 [cited by applicant]
US 20160070245A1 · Lee et al. · 2016 [cited by applicant]
US 20160089053A1 · Lee et al. · 2016 [cited by applicant]
US 20160113526A1 · Nageshwar et al. · 2016 [cited by applicant]
US 20160128586A1 · Parton et al. · 2016 [cited by applicant]
US 20160128604A1 · Eom et al. · 2016 [cited by applicant]
US 20160128637A1 · LeBoeuf et al. · 2016 [cited by applicant]
US 20160183813A1 · Naima · 2016 [cited by examiner]
US 20160206220A9 · Robinson · 2016 [cited by applicant]
US 20170100052A1 · Jung · 2017 [cited by examiner]
US 20180110465A1 · Naima · 2018 [cited by applicant]
US 20180317781A1 · Naima · 2018 [cited by applicant]
US 20200163578A1 · Aliverti · 2020 [cited by examiner]
CA 2333062A1 · 1999 [cited by applicant]
CA 2375249A1 · 2000 [cited by applicant]
CA 2539547A1 · 2005 [cited by applicant]
CA 2578106A1 · 2005 [cited by applicant]
CN 101730503A · 2010 [cited by applicant]
CN 103815888A · 2016 [cited by applicant]
EP 0985429B1 · 2004 [cited by applicant]
EP 2219513B1 · 2012 [cited by applicant]
EP 2687154A1 · 2014 [cited by applicant]
EP 1948017B1 · 2014 [cited by applicant]
EP 2896359A1 · 2015 [cited by applicant]
EP 2155058B1 · 2015 [cited by applicant]
EP 2443993B1 · 2016 [cited by applicant]
EP 1898784B1 · 2016 [cited by applicant]
GB 2316171B · 2000 [cited by applicant]
GB 2393786A · 2004 [cited by applicant]
GB 2425180B · 2009 [cited by applicant]
GB 2520487A · 2015 [cited by applicant]
GB 2523880A · 2015 [cited by applicant]
JP 2001198098A · 2001 [cited by applicant]
JP 2002159473A · 2002 [cited by applicant]
JP 2002282232A · 2002 [cited by applicant]
JP 2006271949A · 2006 [cited by applicant]
JP 3856477B2 · 2006 [cited by applicant]
JP 2008502382A · 2008 [cited by applicant]
JP 2013132326A · 2013 [cited by applicant]
JP 2013233357A · 2013 [cited by applicant]
JP 5587774B2 · 2014 [cited by applicant]
JP 2015002779A · 2015 [cited by applicant]
JP 5687994B2 · 2015 [cited by applicant]
JP 5802748B2 · 2015 [cited by applicant]
JP 5893922B2 · 2016 [cited by applicant]
JP 2019041812A · 2019 [cited by applicant]
KR 20110136113A · 2011 [cited by applicant]
SG 189433A1 · 2013 [cited by applicant]
WO 2008067122A1 · 2008 [cited by applicant]
WO 2009064979A2 · 2009 [cited by applicant]
WO 2010117545A1 · 2010 [cited by applicant]
WO 2011134489A1 · 2011 [cited by applicant]
WO 2013019494A2 · 2013 [cited by applicant]
WO 2013166341A1 · 2013 [cited by applicant]
WO 2014125402A1 · 2014 [cited by applicant]
WO 2014201183A1 · 2014 [cited by applicant]
WO 2014207671A2 · 2014 [cited by applicant]
WO 2015036289A1 · 2015 [cited by applicant]
WO 2015084376A1 · 2015 [cited by applicant]
WO 2015087164A1 · 2015 [cited by applicant]
WO 2015102589A1 · 2015 [cited by applicant]
WO 2015102591A1 · 2015 [cited by applicant]
WO 2015116163A1 · 2015 [cited by applicant]
WO 2015116891A1 · 2015 [cited by applicant]
WO 2015130413A1 · 2015 [cited by applicant]
WO 2015131065A1 · 2015 [cited by applicant]
WO 2015150199A1 · 2015 [cited by applicant]
WO 2015150434A1 · 2015 [cited by applicant]
WO 2016000986A1 · 2016 [cited by applicant]
WO 2016037991A1 · 2016 [cited by applicant]
WO 2016040253A · 2016 [cited by applicant]
WO 2016040264A · 2016 [cited by applicant]
WO 2016069082A · 2016 [cited by applicant]
WO 2016100145A · 2016 [cited by applicant]
Notice of Reasons for Refusal mailed Oct. 31, 2023 in corresponding Japanese Patent Application No. 2021-532500, 4 pages (with Translation). [cited by applicant]
Adamson et al.; “Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device”; Circulation; 110 (16); … [cited by applicant]
Anand et al; “Design and performance of a multisensor heart failure monitoring algorithm: results from the multisensor monitoring in congestive heart failure (MUSIC) study”; J. Card Fail; 18(4); pp. 289-295; Apr. 2012. [cited by applicant]
Bouchaala et al.; Portable bioimpedance spectrometer for total frequency range of beta-dispersion; tm-Technisches Messen Im—Technisches; 80(11 ); pp. 373-378; Nov. 1, 2013. [cited by applicant]
Cowie et al; “Development and validation of an integrated diagnostic algorithm derived from parametersmonitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory … [cited by applicant]
Goetze et al; “Ambulatory respiratory rate trends identify patients at higher risk of worsening heart failure in implantable cardioverter defibrillator and biventricular device recipients: a novel ambulatory parameter t… [cited by applicant]
Joseph et al; Acute Decompensated Heart Failure;11 Tex Heart Inst J.; 36(6); pp. 510-520; (year of pub. sufficiently earlier than effective US filing date and any foreign priority date) 2009. [cited by applicant]
Maurer et al; Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure TherapyStudy (LAPTOP-HFt; J. Card Fail; 21 (6); pp. 479 488; Jun. 2015. [cited by applicant]
Whellan et al; “Combined Heart Failure Device Diagnostics Identify Patients at Higher Risk of Subsequent Heart Failure Hospitalizations”; J. Am. Coll. Cardio!.; 55(17); pp. 1803 181 O; Apr. 27, 2010. [cited by applicant]
Yang et al.; Design and preliminary evaluation of a portable device for the measurement of bioimpedance spectroscopy; Physiol. Meas.; 27(12); pp. 1293-1310; Dec. 2006. [cited by applicant]